These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 19135089

  • 1. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection.
    Chris Maple PA, Gray J, Brown K, Brown D.
    J Virol Methods; 2009 Apr; 157(1):90-2. PubMed ID: 19135089
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay.
    Maple PA, Rathod P, Smit E, Gray J, Brown D, Boxall EH.
    J Clin Virol; 2009 Jan; 44(1):9-14. PubMed ID: 18823815
    [Abstract] [Full Text] [Related]

  • 3. Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals.
    Chris Maple PA, Gunn A, Sellwood J, Brown DW, Gray JJ.
    J Virol Methods; 2009 Feb; 155(2):143-9. PubMed ID: 18996415
    [Abstract] [Full Text] [Related]

  • 4. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test.
    Sauerbrei A, Färber I, Brandstädt A, Schacke M, Wutzler P.
    J Virol Methods; 2004 Jul; 119(1):25-30. PubMed ID: 15109817
    [Abstract] [Full Text] [Related]

  • 5. Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay.
    Maple PA, Gray J, Breuer J, Kafatos G, Parker S, Brown D.
    Clin Vaccine Immunol; 2006 Feb; 13(2):214-8. PubMed ID: 16467328
    [Abstract] [Full Text] [Related]

  • 6. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
    Sauerbrei A, Wutzler P.
    Clin Lab; 2009 Feb; 55(1-2):1-7. PubMed ID: 19350844
    [Abstract] [Full Text] [Related]

  • 7. The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay.
    Maple PA, Haedicke J, Quinlivan M, Steinberg SP, Gershon AA, Brown KE, Breuer J.
    Epidemiol Infect; 2016 Aug; 144(11):2345-53. PubMed ID: 27018820
    [Abstract] [Full Text] [Related]

  • 8. Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workers.
    Maple PA, Breuer J, Quinlivan M, Kafatos G, Brown KE.
    J Clin Virol; 2012 Mar; 53(3):201-7. PubMed ID: 22261123
    [Abstract] [Full Text] [Related]

  • 9. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
    Sauerbrei A, Wutzler P.
    J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
    [Abstract] [Full Text] [Related]

  • 10. Follow-up of pregnant women exposed to chicken pox: an audit of relationship between level of antibody and development of chicken pox.
    Boxall EH, Maple PA, Rathod P, Smit E.
    Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1193-200. PubMed ID: 21455665
    [Abstract] [Full Text] [Related]

  • 11. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
    Jenke AC, Klein S, Baiker A, Wirth S, Sander M, Noelting C, Boecher O, Vizoso-Pinto MG.
    Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
    [Abstract] [Full Text] [Related]

  • 12. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
    Heininger U, Desgrandchamps D, Schaad UB.
    Vaccine; 2006 Apr 12; 24(16):3258-60. PubMed ID: 16459000
    [Abstract] [Full Text] [Related]

  • 13. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.
    Hammond O, Wang Y, Green T, Antonello J, Kuhn R, Motley C, Stump P, Rich B, Chirmule N, Marchese RD.
    J Med Virol; 2006 Dec 12; 78(12):1679-87. PubMed ID: 17063506
    [Abstract] [Full Text] [Related]

  • 14. [Seroepidemiology of varicella-zoster virus infection measured by the fluorescent antibody to membrane antigen test].
    Liu JJ, Wang ML, Gan L, Liao WJ, Chen J.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Apr 12; 30(4):371-5. PubMed ID: 19731531
    [Abstract] [Full Text] [Related]

  • 15. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J, Schmid DS, Gershon AA.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workers.
    McDonald SL, Maple PA, Andrews N, Brown KE, Ayres KL, Scott FT, Al Bassam M, Gershon AA, Steinberg SP, Breuer J.
    J Virol Methods; 2011 Mar 01; 172(1-2):60-5. PubMed ID: 21192976
    [Abstract] [Full Text] [Related]

  • 17. Varicella immunity: persistent serologic non-response to immunization.
    Katial RK, Ratto-Kim S, Sitz KV, Moriarity R, Engler RJ.
    Ann Allergy Asthma Immunol; 1999 May 01; 82(5):431-4. PubMed ID: 10353572
    [Abstract] [Full Text] [Related]

  • 18. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
    Grose C.
    Mol Biol Med; 1989 Oct 01; 6(5):453-62. PubMed ID: 2560525
    [Abstract] [Full Text] [Related]

  • 19. A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid.
    Kneitz RH, Schubert J, Tollmann F, Zens W, Hedman K, Weissbrich B.
    BMC Infect Dis; 2004 Sep 08; 4():33. PubMed ID: 15355548
    [Abstract] [Full Text] [Related]

  • 20. Enzyme-linked immunosorbent assay for detection of antibodies to varicella zoster virus.
    Goldberg RD, Sarov I.
    Isr J Med Sci; 1980 Feb 08; 16(2):111-7. PubMed ID: 6245042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.